Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
OPRX	OPTIMIZERX CORP	$92.70M	5.50%	4.00%	9.40%	31.00%	0.29	5.37	70.00%	6.40%	13.73%
HAE	HAEMONETICS CORP	$2.81B	11.30%	4.00%	7.42%	8.50%	2.01	2.95	59.00%	7.30%	11.75%
AGEN	AGENUS INC	$131.59M	-23.00%	30.90%	-193.93%	658.20%	-1.87	0.38	99.30%	52.00%	98.29%
AUNA	AUNA SA	$324.92M	N/A	N/A	N/A	N/A	N/A	N/A	37.90%	1.50%	17.40%
ZBH	ZIMMER BIOMET HOLDINGS INC	$16.50B	6.00%	3.30%	6.04%	9.40%	0.79	1.73	70.00%	9.10%	14.26%
SLP	SIMULATIONS PLUS INC	$305.30M	-49.30%	-45.60%	-49.42%	-243.70%	0.10	5.47	62.00%	-78.00%	-82.32%
HSTM	HEALTHSTREAM INC	$691.52M	5.70%	3.90%	6.60%	48.90%	0.50	0.97	64.90%	6.40%	8.27%
ILMN	ILLUMINA INC	$21.91B	34.00%	13.40%	23.23%	24.90%	1.45	1.75	66.20%	19.40%	26.41%
HALO	HALOZYME THERAPEUTICS INC	$8.13B	126.30%	14.70%	22.62%	21.60%	11.17	2.76	82.80%	23.10%	34.64%
EHC	ENCOMPASS HEALTH CORP	$10.36B	25.30%	8.70%	14.61%	13.10%	1.57	1.17	27.50%	10.00%	15.50%
IRMD	IRADIMED CORP	$1.19B	24.50%	21.30%	29.51%	71.00%	0.16	7.13	76.80%	27.40%	34.98%
ENSG	ENSIGN GROUP INC	$10.03B	16.60%	6.80%	10.19%	8.00%	1.37	1.56	15.90%	6.90%	9.20%
LMAT	LEMAITRE VASCULAR INC	$2.27B	16.20%	10.30%	14.39%	13.60%	0.55	14.32	72.40%	24.30%	33.48%
BMRN	BIOMARIN PHARMACEUTICAL INC	$10.46B	4.40%	3.40%	5.24%	7.10%	0.38	5.81	76.50%	8.30%	12.60%
BIIB	BIOGEN INC	$27.97B	7.50%	4.70%	6.13%	12.00%	0.58	3.07	75.50%	13.80%	16.33%
IRTC	IRHYTHM HOLDINGS INC	$3.87B	-20.60%	-2.80%	-1.58%	-1.00%	5.24	5.17	71.00%	-3.50%	-1.75%
ATEC	ALPHATEC HOLDINGS INC	$1.27B	-1,183.80%	-15.80%	-13.50%	-8.80%	-150.52	1.90	70.20%	-15.90%	-9.59%
PFE	PFIZER INC	$147.90B	8.40%	3.60%	4.54%	7.10%	1.30	1.25	73.50%	11.80%	12.44%
ANIK	ANIKA THERAPEUTICS INC	$199.85M	-7.70%	-5.90%	-6.47%	-8.00%	0.34	4.46	58.60%	-9.50%	-8.81%
CVS	CVS HEALTH CORP	$119.07B	3.90%	1.10%	3.96%	5.40%	2.26	0.87	13.90%	0.70%	1.62%
CI	CIGNA GROUP	$74.60B	15.20%	4.10%	9.29%	18.00%	2.63	0.82	9.10%	2.30%	3.37%
ATRC	ATRICURE INC	$1.46B	-1.00%	-0.70%	0.45%	1.20%	0.31	4.29	75.60%	-0.80%	0.46%
AHCO	ADAPTHEALTH CORP	$1.43B	-5.10%	-1.80%	1.85%	2.40%	1.93	0.93	18.30%	-2.40%	2.07%
GKOS	GLAUKOS CORP	$8.17B	-26.50%	-20.10%	-23.63%	-32.40%	0.33	5.43	57.60%	-34.30%	-34.45%
NVO	NOVO NORDISK A S	$198.20B	66.40%	23.30%	46.60%	55.60%	1.75	0.79	81.80%	37.20%	47.49%
DGX	QUEST DIAGNOSTICS INC	$21.46B	14.10%	6.30%	11.13%	17.00%	1.22	1.18	33.20%	9.10%	14.30%
AXGN	AXOGEN INC	$2.20B	-20.70%	-13.50%	-9.61%	-11.80%	0.18	7.10	75.00%	-13.20%	-10.63%
MCK	MCKESSON CORP	$92.14B	-265.40%	5.70%	39.93%	93.90%	-38.72	0.85	3.60%	1.20%	1.51%
EW	EDWARDS LIFESCIENCES CORP	$47.91B	10.60%	8.20%	11.26%	19.70%	0.29	4.42	77.90%	17.40%	21.28%
ZVRA	ZEVRA THERAPEUTICS INC	$620.12M	81.30%	45.60%	60.94%	67.80%	0.35	4.89	86.10%	101.60%	115.40%
AMGN	AMGEN INC	$182.11B	89.40%	8.60%	17.43%	16.40%	9.07	1.26	68.30%	21.00%	31.64%
ENTA	ENANTA PHARMACEUTICALS INC	$402.15M	-64.00%	-20.20%	-19.19%	-18.40%	1.70	3.84	100.00%	-89.60%	-74.39%
PNTG	PENNANT GROUP INC	$1.20B	9.20%	3.50%	6.24%	6.90%	1.64	1.19	13.80%	3.00%	5.05%
ARDT	ARDENT HEALTH INC	$1.32B	10.50%	2.60%	5.69%	5.00%	2.63	2.12	18.40%	2.10%	3.80%
OMDA	OMADA HEALTH INC	$977.33M	-2.80%	-2.10%	-2.06%	-52.10%	0.29	3.92	66.30%	-2.20%	-1.70%
PGEN	PRECIGEN INC	$1.53B	-3,317.10%	-270.30%	-168.17%	-128.90%	5.85	4.82	80.10%	-1,213.50%	-625.55%
MRVI	MARAVAI LIFESCIENCES HOLDINGS INC	$1.16B	-44.70%	-14.80%	-12.40%	-14.70%	1.63	5.91	29.30%	-51.10%	-40.60%
NEOG	NEOGEN CORP	$1.93B	-29.00%	-18.00%	-17.63%	-38.40%	0.60	3.92	45.20%	-69.90%	-64.99%
AIRS	AIRSCULPT TECHNOLOGIES INC	$371.07M	-12.40%	-5.90%	-7.29%	-10.10%	0.92	0.75	59.60%	-7.40%	-7.66%
ISRG	INTUITIVE SURGICAL INC	$155.76B	17.00%	14.90%	19.58%	25.50%	0.14	4.61	66.30%	28.20%	33.67%
ORMP	ORAMED PHARMACEUTICALS INC	$179.26M	55.30%	49.90%	45.10%	64.80%	0.13	6.45	N/A	N/A	N/A
OMER	OMEROS CORP	$865.61M	-54.40%	34.50%	39.48%	16.70%	-5.52	3.03	94.10%	871.00%	904.87%
JNJ	JOHNSON & JOHNSON	$557.82B	26.30%	10.70%	18.14%	34.70%	1.47	1.03	67.80%	21.80%	26.96%
WAY	WAYSTAR HOLDING CORP	$3.61B	3.50%	2.40%	4.71%	16.70%	0.48	1.76	68.70%	10.90%	22.87%
VCEL	VERICEL CORP	$1.80B	6.40%	4.60%	5.24%	5.50%	0.36	5.18	74.80%	7.30%	7.86%
SPRO	SPERO THERAPEUTICS INC	$155.76M	35.60%	25.00%	28.95%	165.70%	0.12	10.50	100.00%	24.90%	25.33%
INNV	INNOVAGE HOLDING CORP	$1.00B	-4.80%	-2.20%	-1.52%	-2.20%	1.26	1.03	21.80%	-1.20%	-0.56%
COR	CENCORA INC	$51.64B	115.90%	3.30%	15.19%	46.20%	22.98	0.95	3.80%	0.80%	1.18%
IDXX	IDEXX LABORATORIES INC	$43.63B	70.90%	32.60%	67.53%	56.30%	1.18	1.12	62.10%	24.60%	31.68%
CHE	CHEMED CORP	$5.86B	25.30%	16.20%	28.89%	60.50%	0.81	0.85	32.40%	10.20%	13.81%
RMD	RESMED INC	$30.31B	24.40%	18.00%	25.19%	59.10%	0.35	3.01	61.60%	27.40%	33.82%
PRLD	PRELUDE THERAPEUTICS INC	$344.86M	-118.20%	-66.10%	-99.84%	-117.90%	0.99	2.03	100.00%	-465.30%	-465.30%
PARK	PARK DENTAL PARTNERS INC	$83.03M	N/A	N/A	N/A	N/A	6.07	1.07	N/A	N/A	N/A
GRFS	GRIFOLS SA	$5.58B	7.20%	2.00%	6.45%	6.50%	2.30	2.51	38.00%	5.30%	15.18%
FTRE	FORTREA HOLDINGS INC	$1.24B	-79.10%	-16.30%	-20.47%	-28.40%	4.10	0.95	18.90%	-16.50%	-13.26%
VRTX	VERTEX PHARMACEUTICALS INC	$110.03B	23.90%	17.20%	22.90%	31.70%	0.37	3.02	86.20%	35.50%	42.36%
MRK	MERCK & CO INC	$286.20B	17.90%	7.00%	12.93%	14.50%	1.80	1.30	73.90%	13.60%	20.00%
BSX	BOSTON SCIENTIFIC CORP	$84.95B	14.90%	8.30%	10.32%	18.10%	0.71	1.90	69.20%	17.30%	19.91%
PRTA	PROTHENA CORP PUBLIC LTD CO	$492.64M	-49.90%	-42.30%	-33.63%	622.40%	0.12	10.43	100.00%	-260.90%	-184.21%
ALC	ALCON INC	$33.13B	3.70%	2.60%	4.17%	8.50%	0.43	2.20	55.40%	7.70%	11.22%
ARGX	ARGENX SE	$50.51B	20.20%	17.40%	17.42%	34.00%	0.19	5.23	N/A	N/A	N/A
VEEV	VEEVA SYSTEMS INC	$25.85B	13.40%	11.10%	16.27%	25.10%	0.25	4.89	75.50%	28.40%	37.38%
DHR	DANAHER CORP	$122.68B	7.10%	4.50%	6.06%	16.20%	0.58	1.87	58.90%	14.90%	18.60%
TEVA	TEVA PHARMACEUTICAL INDUSTRIES LTD	$39.78B	20.70%	3.90%	8.68%	10.40%	3.87	1.01	52.10%	9.00%	13.27%
NNNN	ANBIO BIOTECHNOLOGY	$4.35B	27.00%	26.00%	21.24%	46.00%	0.00	344.31	87.20%	74.10%	74.06%
NEO	NEOGENOMICS INC	$1.19B	-11.80%	-7.20%	-7.88%	-13.90%	0.63	4.42	43.20%	-13.30%	-13.33%
DERM	JOURNEY MEDICAL CORP	$170.99M	-35.60%	-10.90%	-10.85%	-26.10%	1.97	1.72	65.40%	-14.80%	-9.01%
MASS	908 DEVICES INC	$269.23M	-25.60%	-19.00%	-24.58%	-64.80%	0.39	3.58	51.50%	-62.40%	-62.52%
CUE	CUE BIOPHARMA INC	$81.32M	-98.30%	-53.70%	-80.25%	-306.00%	0.43	3.57	100.00%	-59.60%	-57.58%
AMRN	AMARIN CORP PLC	$305.10M	-7.30%	-5.10%	-6.58%	-9.20%	0.44	3.49	52.40%	-15.50%	-14.15%
STTK	SHATTUCK LABS INC	$466.98M	-60.70%	-55.70%	-50.96%	-188.80%	0.07	22.07	100.00%	-4,987.40%	-4,987.40%
LMRI	LUMEXA IMAGING HOLDINGS INC	$785.94M	N/A	N/A	N/A	N/A	1.94	1.41	N/A	N/A	N/A
SRPT	SAREPTA THERAPEUTICS INC	$1.79B	4.90%	1.90%	0.91%	0.80%	1.11	4.63	62.90%	3.00%	1.12%
APYX	APYX MEDICAL CORP	$177.96M	-90.60%	-14.90%	-6.02%	-5.30%	3.89	5.80	63.20%	-16.40%	-5.77%
ACHC	ACADIA HEALTHCARE COMPANY INC	$2.12B	-43.80%	-18.60%	-18.41%	-15.60%	1.73	1.71	34.40%	-32.80%	-27.62%
CLOV	CLOVER HEALTH INVESTMENTS CORP	$1.90B	-17.10%	-9.60%	-15.77%	-28.80%	1.06	1.33	18.40%	-2.60%	-2.58%
MEDP	MEDPACE HOLDINGS INC	$12.28B	120.90%	24.80%	71.25%	-144.40%	2.56	0.85	29.10%	17.20%	20.87%
NHC	NATIONAL HEALTHCARE CORP	$3.06B	11.70%	8.00%	12.98%	15.40%	0.39	1.86	100.00%	8.10%	10.83%
TVTX	TRAVERE THERAPEUTICS INC	$4.16B	-26.80%	-3.80%	-2.42%	-1.90%	4.62	3.13	98.60%	-4.00%	-1.94%
TMO	THERMO FISHER SCIENTIFIC INC	$167.00B	13.20%	6.40%	8.96%	14.90%	1.18	1.53	40.80%	15.20%	19.56%
TARS	TARSUS PHARMACEUTICALS INC	$2.73B	-14.20%	-8.90%	-8.00%	-9.70%	0.67	3.74	93.50%	-9.00%	-6.54%
PDEX	PRO DEX INC	$199.90M	29.10%	18.30%	27.94%	27.90%	0.66	3.67	27.80%	16.10%	22.59%
CCLD	CARECLOUD INC	$100.28M	7.40%	5.10%	16.23%	60.20%	0.49	1.11	47.00%	3.50%	8.27%
WEAV	WEAVE COMMUNICATIONS INC	$446.36M	-30.90%	-12.10%	-19.66%	-27.60%	1.45	1.24	72.30%	-10.10%	-9.74%
BWAY	BRAINSWAY LTD	$590.62M	12.20%	7.70%	11.56%	36.60%	0.54	3.34	75.50%	15.60%	19.21%
OABI	OMNIAB INC	$369.68M	-20.30%	-18.10%	-19.73%	-78.00%	0.12	4.80	98.90%	-187.60%	-190.93%
A	AGILENT TECHNOLOGIES INC	$32.44B	19.70%	10.30%	14.57%	21.40%	0.86	2.07	52.20%	18.30%	21.81%
TOI	ONCOLOGY INSTITUTE INC	$446.92M	N/A	-28.40%	-43.96%	-26.30%	-11.33	1.47	15.10%	-8.50%	-7.16%
INVA	INNOVIVA INC	$1.64B	47.60%	32.40%	34.30%	58.30%	0.37	21.13	73.70%	119.90%	146.77%
SYK	STRYKER CORP	$120.18B	15.10%	7.10%	13.40%	19.50%	1.01	2.11	63.80%	13.20%	21.19%
HQY	HEALTHEQUITY INC	$7.30B	10.10%	6.30%	10.38%	27.20%	0.60	3.27	69.50%	16.40%	25.47%
LAB	STANDARD BIOTOOLS INC	$405.98M	17.30%	13.60%	6.78%	11.70%	0.14	12.36	49.60%	90.70%	46.93%
GILD	GILEAD SCIENCES INC	$162.02B	42.20%	16.10%	25.07%	31.10%	1.40	1.97	79.40%	31.00%	39.45%
WAT	WATERS CORP	$33.48B	8.00%	4.60%	2.82%	14.10%	0.60	1.79	55.20%	11.90%	16.64%
ARQT	ARCUTIS BIOTHERAPEUTICS INC	$2.63B	-1.40%	-0.60%	4.07%	3.70%	1.43	2.68	90.90%	-0.60%	2.91%
UHS	UNIVERSAL HEALTH SERVICES INC	$9.83B	21.00%	9.90%	17.26%	16.00%	1.09	1.08	43.40%	8.60%	12.09%
HCWB	HCW BIOLOGICS INC	$17.37M	-1,138.00%	-68.20%	-17.38%	-16.20%	3.75	0.09	100.00%	-277.00%	-19.61%
ELV	ELEVANCE HEALTH INC	$84.65B	12.00%	4.30%	9.49%	12.10%	1.86	1.48	15.10%	2.60%	3.81%
RGEN	REPLIGEN CORP	$6.39B	2.50%	1.80%	2.78%	5.90%	0.39	9.20	52.90%	6.70%	10.23%
KRMD	KORU MEDICAL SYSTEMS INC	$190.16M	-13.60%	-8.30%	-11.43%	-16.30%	0.69	2.33	61.90%	-5.30%	-5.22%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	602	+0.98%	-2.57%	-1.90%	-76.05%	18.28x	4.87x	-122.61%	-12.79%	-9.65%	+63.30%	Strong Buy
Diagnostics & Research	55	+0.67%	+2.81%	-8.17%	+10.83%	15.48x	3.33x	-6.63%	+6.21%	+12.47%	+27.83%	Strong Buy
Drug Manufacturers - General	20	+1.56%	+1.86%	+5.32%	+34.81%	35.69x	7.08x	+34.51%	+12.30%	+21.70%	+16.21%	Buy
Drug Manufacturers - Specialty & Generic	75	+1.45%	+0.08%	-0.21%	-29.54%	10.90x	1.56x	+9.35%	+5.09%	+10.99%	+40.37%	Buy
Healthcare Plans	10	-0.67%	-2.56%	+17.39%	-0.56%	26.31x	2.31x	+9.02%	+2.82%	+6.93%	+0.78%	Buy
Health Information Services	53	-0.32%	+2.09%	+1.61%	-27.61%	18.03x	2.95x	-3.94%	+0.71%	+1.12%	+39.60%	Buy
Medical Care Facilities	50	-0.91%	-2.48%	+4.38%	-21.64%	15.15x	4.82x	-49.93%	+6.78%	+15.36%	+22.72%	Buy
Medical Devices	139	+0.14%	+3.57%	-2.51%	-69.30%	23.09x	3.04x	+6.44%	+5.41%	+9.00%	+33.12%	Strong Buy
Medical Distribution	10	+1.07%	+2.30%	-9.07%	+5.35%	22.37x	143.42x	-104.83%	+3.78%	+25.68%	+28.40%	Buy
Medical Instruments & Supplies	55	+0.20%	+3.38%	-1.50%	-5.73%	42.68x	3.27x	+7.01%	+7.29%	+10.77%	+27.03%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: A, Growth: A, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 47, which is 20 points higher than the healthcare sector average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 42.55% over the past year, overperforming other healthcare stocks by 102 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 57.98% from Bioventus's current stock price of $9.50.

Bioventus stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Bioventus, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

Jazz Pharmaceuticals (NASDAQ:JAZZ) is the #2 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Jazz Pharmaceuticals (NASDAQ:JAZZ) is: Value: A, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: C.

Jazz Pharmaceuticals (NASDAQ:JAZZ) has a Due Diligence Score of 34, which is 7 points higher than the healthcare sector average of 27. It passed 11 out of 33 due diligence checks and has average fundamentals. Jazz Pharmaceuticals has seen its stock return 122.45% over the past year, overperforming other healthcare stocks by 181 percentage points.

Jazz Pharmaceuticals has an average 1 year price target of $251.09, an upside of 4.88% from Jazz Pharmaceuticals's current stock price of $239.40.

Jazz Pharmaceuticals stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 11 analysts covering Jazz Pharmaceuticals, 72.73% have issued a Strong Buy rating, 27.27% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Indivior Pharmaceuticals (NASDAQ:INDV)

Indivior Pharmaceuticals (NASDAQ:INDV) is the #3 top healthcare stock out of 1069 with a Zen Rating of A. Stocks with a rating of A have had an average return of +32.52% per year. Learn more.

The Component Grade breakdown for Indivior Pharmaceuticals (NASDAQ:INDV) is: Value: B, Growth: B, Momentum: C, Sentiment: A, Safety: B, Financials: B, and AI: C.

Indivior Pharmaceuticals (NASDAQ:INDV) has a Due Diligence Score of 41, which is 14 points higher than the healthcare sector average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Indivior Pharmaceuticals has seen its stock return 234.79% over the past year, overperforming other healthcare stocks by 294 percentage points.

Indivior Pharmaceuticals has an average 1 year price target of $48.00, an upside of 28.14% from Indivior Pharmaceuticals's current stock price of $37.46.

Indivior Pharmaceuticals stock has a consensus Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Indivior Pharmaceuticals, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 75 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Cryo Cell International (NYSEMKT:CCEL)

Cryo Cell International (NYSEMKT:CCEL) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

Cryo Cell International's dividend payout ratio of -45.5% indicates that its dividend yield might not be sustainable for the long-term.

2. So Young International (NASDAQ:SY)

So Young International (NASDAQ:SY) has an annual dividend yield of N/A, which is N/A percentage points lower than the healthcare sector average of 2.66%.

So Young International's dividend payout ratio of 0% indicates that its dividend yield might not be sustainable for the long-term.

3. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 30.19%, which is 28 percentage points higher than the healthcare sector average of 2.66%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.58% in the last day, and up 0.01% over the last week. Akari Therapeutics was the among the top gainers in the healthcare sector, gaining 255.45% yesterday.

Akari Therapeutics shares are trading higher after the company announced preclinical data demonstrating synergistic activity of AKTX-101 with KRAS inhibition in KRAS-mutated pancreatic cancer models

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 57, which is 42 points higher than the healthcare sector average of 15. It passed 4 out of 7 valuation due diligence checks.

Embecta's stock has dropped -68.4% in the past year. It has underperformed other stocks in the healthcare sector by -9 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 71 points higher than the healthcare sector average of 15. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 532.26% in the past year. It has overperformed other stocks in the healthcare sector by 591 percentage points.

3. Auna Sa (NYSE:AUNA)

Auna Sa (NYSE:AUNA) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Auna Sa has a valuation score of 43, which is 28 points higher than the healthcare sector average of 15. It passed 3 out of 7 valuation due diligence checks.

Auna Sa's stock has dropped -36.8% in the past year. It has overperformed other stocks in the healthcare sector by 22 percentage points.

Are healthcare stocks a good buy now?

60.49% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 39.89% over the next year.

4.95% of healthcare stocks have a Zen Rating of A (Strong Buy), 12.38% of healthcare stocks are rated B (Buy), 48.14% are rated C (Hold), 27.48% are rated D (Sell), and 7.05% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 27.77x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. Cryo Cell International (NYSEMKT:CCEL)

2. So Young International (NASDAQ:SY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Jazz Pharmaceuticals (NASDAQ:JAZZ)

3. Indivior Pharmaceuticals (NASDAQ:INDV)

1. Cryo Cell International (NYSEMKT:CCEL)

2. So Young International (NASDAQ:SY)

3. Dominari Holdings (NASDAQ:DOMH)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Auna Sa (NYSE:AUNA)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.